PERCEPT · BIO-NAT-2012-01
Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.
A postauthorization observational study assessing how JC virus antibody test results affect perceived risk of natalizumab (Tysabri) treatment among patients with multiple sclerosis and their neurologists.
Sponsor: BIOGEN
Phase: IV
Area: Neuroimmunology